Expression of Human Leukocyte Antigen-G in Placental Tissues from Pregnant Women with Preeclampsia
American Journal of Life Sciences
Volume 8, Issue 1, June 2020, Pages: 14-18
Received: Jun. 28, 2020;
Published: Jun. 29, 2020
Views 23 Downloads 30
Yongmei Li, Department of Gynecology, Binzhou People's Hospital, Binzhou, P.R. China
Yubin Zhang, Department of Nuclear Medicine, Binzhou People's Hospital, Binzhou, P.R. China
Jinfang Wang, Department of Gynecology, Binzhou People's Hospital, Binzhou, P.R. China
Objective: To study the gene and protein expressions of human leukocyte antigen-G (HLA-G) in the placental tissues from healthy women in late pregnancy and pregnant women with preeclampsia (PE), and to explore the relationship between HLA-G and PE. Methods: Immunohistochemistry, Western blot and RT-PCR were used to detect the expressions of HLA-G protein and mRNA in the maternal placenta of 60 pregnant women with PE (including 30 cases of mild PE and 30 cases of severe PE) and 30 healthy full-term pregnant women (control group) respectively. Results: HLA-G had its expression mainly on the surface of trophoblast cells, and its response range and reactivity of its immunologic tissue were further reduced and weakened as the patient's condition was aggravated. The protein expression of placental HLA-G in each PE group was significantly lower than control group, with the difference statistically significant (all P<0.05). Compared with mild PE group, the protein expression level of HLA-G was lower in severe PE group (P<0.05). The Spearman's correlation analysis for HLA-G and PE severity showed that the correlation coefficient was -0.892 (rs = -0.892) (P<0.05), indicating that the expression of HLA-G protein was significantly negatively correlated to the severity of PE. The mRNA expression level of placental HLA-G of each PE group was significantly lower than that of control group, and the difference was statistically significant (all P<0.05). But the mRNA expression level of HLA-G was significantly lower in severe PE group than in mild PE group (P<0.05). Conclusion: The decreased expression of HLA-G in placenta may be involved in the pathogenesis of PE, and can also reflect the severity of this disease.
Expression of Human Leukocyte Antigen-G in Placental Tissues from Pregnant Women with Preeclampsia, American Journal of Life Sciences.
Vol. 8, No. 1,
2020, pp. 14-18.
Laskowska M, Laskowska K, Oleszczuk J. Differences in the Association between Maternal Serum Homocysteine and ADMA Levels in Women with Pregnancies Complicated by Preeclampsia and/or Intrauterine Growth Restriction. Hypertens Pregnancy 2020; 31: 83-93.
Scholten RR, Hopman MT, Sweep FC, et al. Co-occurrence of cardiovascular and prothrombotic risk factors in women with a history of preeclampsia. Obstet Gynecol 2019; 121: 97-105.
Scazzocchio E, Figueras F, Crispi F, et al. Performance of a first-trimester screening of preeclampsia in a routine care low-risk setting. Am J Obstet Gynecol 2019; 208: 203-210.
Warner CM, Lampton PW, Newmark JA, Cohen J. Symposium: innovative techniques in human embryo viability assessment. Soluble human leukocyte antigen-G and pregnancy success. Reprod Biomed Online 2018; 17: 470-485.
Rizzo R, Andersen AS, Lassen MR, et al. Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy. Am J Reprod Immunol 2019; 62: 320-338.
Bezerra Maia E Holanda Moura S, Marques Lopes L, Murthi P, da Silva Costa F. Prevention of preeclampsia. J Pregnancy 2017; 15: 90-96.
Walpole NG, Kjer-Nielsen L, Kostenko L, et al. The structure and stability of the monomorphic HLA-G are influenced by the nature of the bound peptide. J Mol Biol 2018; 397: 467-480.
Castelli EC, Mendes-Junior CT, Deghaide NH, et al. The genetic structure of 3'untranslated region of the HLA-G gene: polymorphisms and haplotypes. Genes Immun 2019; 11: 134-141.
Kolte AM, Steffensen R, Nielsen HS, Hviid TV, Christiansen OB. Study of the structure and impact of human leukocyte antigen (HLA)-G-A, HLA-G-B, and HLA-G-DRB1 haplotypes in families with recurrent miscarriage. Hum Immunol 2019; 71 (5): 482-488.
Agaugué S, Carosella ED, Rouas-Freiss N. Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17. Blood 2019; 117: 7021-7031.
Chen BG, Xu DP, Lin A, Yan WH. NK cytolysis is dependent on the proportion of HLA-G expression. Hum Immunol 2018; 74: 286-289.
Darmochwal-Kolarz D, Kolarz B, Rolinski J, Leszczynska-Gorzelak B, Oleszczuk J. The concentrations of soluble HLA-G protein are elevated during mid-gestation and decreased in pre-eclampsia. Folia Histochem Cytobiol 2017; 50: 286-291.
Zhang Z, Li Y, Zhang LL, Jia LT, Yang XQ. Association of 14 bp insertion/deletion polymorphism of the HLA-G gene in father with severe preeclampsia in Chinese. Tissue Antigens 2017; 80: 158-164.
Tan CY, Chong YS, Loganath A, et al. Possible gene-gene interaction of KIR2DL4 with its cognate ligand HLA-G in modulating risk for preeclampsia. Reprod Sci 2019; 16: 1135-1143.
Moreau P, Contu L, Alba F, et al. HLA-G gene polymorphism in human placentas: possible association of G*0106 allele with preeclampsia and miscarriage. Biol Reprod 2018; 79: 459-467.
Zhou X, Zhang GY, Wang J, Lu SL, Cao J, Sun LZ. A novel bridge between oxidative stress and immunity: the interaction between hydrogen peroxide and human leukocyte antigen G in placental trophoblasts during preeclampsia. Am J Obstet Gynecol 2018; 206: 7-16.
Suzuki S. The benefit of labor induction for preeclampsia beyond 37 weeks' gestation. J Matern Fetal Neonatal Med 2018; 23: 1072-1074.
Faupel-Badger JM, Fichorova RN, Allred EN, et al. Cluster analysis of placental inflammatory proteins can distinguish preeclampsia from preterm labor and premature membrane rupture in singleton deliveries less than 28 weeks of gestation. Am J Reprod Immunol 2019; 66: 488-494.
Zhao SC, Li ZB, He TQ, Yu CZ. Relationship between the expression of human leukocyte antigen G and preeclampsia. Zhonghua Fu Chan Ke Za Zhi 2019; 46: 758-762.
Liu CM, Chang SD, Cheng PJ. Relationship between prenatal care and maternal complications in women with preeclampsia: implications for continuity and discontinuity of prenatal care. Taiwan J Obstet Gynecol 2019; 1: 576-582.